MX69 is novel MDM2/XIAP dual inhibitor shown to have a robust cytotoxic effect in acute lymphoblastic leukemia and neuroblastoma cells irrespective of p53 status [22]. The gene discussed is MDM2; the disease is neuroblastoma.